ציפרופלוקסצין טבע 500 מג ישראל - עברית - Ministry of Health

ציפרופלוקסצין טבע 500 מג

teva israel ltd - ciprofloxacin as hydrochloride - טבליה - ciprofloxacin as hydrochloride 500 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.

ציפרופלוקסצין טבע 250 מג ישראל - עברית - Ministry of Health

ציפרופלוקסצין טבע 250 מג

teva pharmaceutical industries ltd, israel - ciprofloxacin as hydrochloride - טבליה - ciprofloxacin as hydrochloride 250 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.

ציפרופלוקסצין טבע 750 מג ישראל - עברית - Ministry of Health

ציפרופלוקסצין טבע 750 מג

teva pharmaceutical industries ltd, israel - ciprofloxacin as hydrochloride - טבליה - ciprofloxacin as hydrochloride 750 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.

אופלוקסצין טבע 200 מג ישראל - עברית - Ministry of Health

אופלוקסצין טבע 200 מג

abic ltd. - ofloxacin - טבליה - ofloxacin 200 mg - ofloxacin - ofloxacin - bacterial infections due to ofloxacin-susceptible microorganisms, such as:- acute, chronic, or recurrent lower respiratory tract infections (bronchitis) pneumonia (not for the treatment of first choice in pnemonia caused by pneumococci). - chronic and recurrent infections of the ear, nose, and throat. ofloxacin is in general not indicated for the treatment of acute tonsillitis caused by betahaemolytic streptococci. - infections of soft tissues and skin. - infections of the bones and joints. - abdominal infections including infections in the pelvis minor and bacterial enteritis. - infections of the kidney, urinary tract, and genital organs, gonorrhoea.prevention of infections due to ofloxacin-susceptible pathogens in patients with a significant reduction in resistance to infections (e.g. in neutropenic state).

אופלודקס ישראל - עברית - Ministry of Health

אופלודקס

dexcel ltd, israel - ofloxacin - קפליות - ofloxacin 200 mg - ofloxacin - ofloxacin - bacterial infections due to ofloxacin-susceptible microorganisms, such as: upper and lower urinary tract infections, lower respiratory tract infections uncomplicated urethral and cervical gonorrhoea, non-gonococcal urethritis and cervicitis, skin and soft tissue infections.

אופלוקס ישראל - עברית - Ministry of Health

אופלוקס

abbvie biopharmaceuticals ltd, israel - ofloxacin - תמיסה לעין - ofloxacin 0.3 % - ofloxacin - ofloxacin - for the treatment of external ocular infections caused by ofloxacin sensitive organisms.

מגאקסין IV ישראל - עברית - Ministry of Health

מגאקסין iv

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

ציפרודקס 500 ישראל - עברית - Ministry of Health

ציפרודקס 500

dexcel ltd, israel - ciprofloxacin as hydrochloride - קפליות - ciprofloxacin as hydrochloride 500 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.

טאבניק טבליות 500 מג ישראל - עברית - Ministry of Health

טאבניק טבליות 500 מג

sanofi israel ltd - levofloxacin as hemihydrate - טבליות מצופות פילם - levofloxacin as hemihydrate 500 mg - levofloxacin - levofloxacin - in adults with infections of mild to moderate severity tavanic tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

לבו ישראל - עברית - Ministry of Health

לבו

unipharm ltd, israel - levofloxacin hemihydrate - טבליה - levofloxacin hemihydrate 500 mg - levofloxacin - levofloxacin - in adults with infections of mild to moderate severity for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.